Orasure Technologies

OraSure Technologies, headquartered in Bethlehem, Pennsylvania, is a leader in the development, manufacturing, and distribution of oral fluid diagnostic and collection devices as well as other technologies used for detecting or diagnosing critical medical conditions. These products include tests for detecting HIV antibodies, such as the OraQuick® In-Home HIV Test, OraQuick Advance® Rapid HIV-1/2 Antibody Test, and OraSure® HIV-1 Oral Specimen Collection Device, as well as hepatitis C virus (HCV) antibody tests like the OraQuick® HCV Rapid Antibody Test, and oral fluid testing solutions for drug use, including Intercept®, the Oral Fluid Drug Testing System, and Q.E.D.® Saliva Alcohol Test. OraSure also manufactures and sells several leading cryosurgical products, including Histofreezer®, a product used for the cryogenic removal of common and plantar warts and other benign skin lesions, sold to the professional or physician office market, as well as over-the-counter products for the cryogenic removal of common and plantar warts. Additionally, through its wholly-owned subsidiary DNA Genotek Inc., the company is a leading provider of oral fluid sample collection, stabilization, and preparation products for molecular diagnostic applications. OraSure’s portfolio of products is sold globally to various clinical laboratories, hospitals, clinics, community organizations, and other public health entities, research and academic institutions, distributors, government agencies, physician offices, and commercial and industrial organizations. Its over-the-counter products are available in pharmacies across North America, South America, Europe, and Australia.